The rapid rise of GLP-1 therapies is driving a profound shift in how consumers approach food, redefining not only eating habits but also the very concept of nutritional value.
The company grows its food ingredients portfolio while gaining recognition for its use of artificial intelligence across the food system.
The new system in Padova shows how design can improve safety and day to day operations in grain processing.
The decision is part of Paulig’s strategy to sharpen focus on the World Foods and Tex Mex categories that drive the company’s long term growth.
The agribusiness firm reported higher losses despite steady revenue growth during the period.